How can we minimise the use of regular oral corticosteroids in asthma?
Open Access
- 4 February 2020
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 29 (155), 190085
- https://doi.org/10.1183/16000617.0085-2019
Abstract
Options to achieve oral corticosteroid (OCS)-sparing have been triggering increasing interest since the 1970s because of the side-effects of OCSs, and this has now become achievable with biologics. The Societe de Pneumologie de Langue Francaise workshop on OCSs aimed to conduct a comprehensive review of the basics for OCS use in asthma and issue key research questions. Pharmacology and definition of regular use were reviewed by the first working group (WG1). WG2 examined whether regular OCS use is associated with T2 endotype. WG3 reported on the specificities of the paediatric area. Key "research statement proposals" were suggested by WG4. It was found that the benefits of regular OCS use in asthma outside episodes of exacerbations are poorly supported by the existing evidence. However, complete OCS elimination couldn't be achieved in any available studies for all patients and the panel felt that it was too early to conclude that regular OCS use could be declared criminal. Repeated or prolonged need for OCS beyond 1 g.year(-1) should indicate the need for referral to secondary/tertiary care. A strategic sequential plan aiming at reducing overall exposure to OCS in severe asthma was then held as a conclusion of the workshop.This publication has 146 references indexed in Scilit:
- Dynamic role of epithelium-derived cytokines in asthmaClinical Immunology, 2012
- Pediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokinesJournal of Allergy and Clinical Immunology, 2012
- Decreased response to inhaled steroids in overweight and obese asthmatic childrenJournal of Allergy and Clinical Immunology, 2011
- Pathophysiology of bronchial smooth muscle remodelling in asthmaEuropean Respiratory Journal, 2010
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Corticosteroid responsiveness and clinical characteristics in childhood difficult asthmaEuropean Respiratory Journal, 2009
- The PDGF signaling pathway controls multiple steroid-producing lineagesGenes & Development, 2008
- Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthmaThe Journal of Experimental Medicine, 2007
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology, 2006